FDA, and the medical system as a whole, to monitor the safety of drugs after they have been approved, and about the power of the regulator to mandate changes to drug labelling and advertising.
ECONOMIST: Pharmaceuticals
2.
Pauline Roberts says she believes the labelling is now strong enough, but she says a lot of the people who have called Smith Llewellyn were prescribed the drug before 1988.